Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Quarterly sales slide at WPP, full-year outlook unchanged

(Sharecast News) - WPP reiterated its full-year outlook on Friday, despite seeing quarterly sales slide amid mounting macroeconomic uncertainty. Reported revenues at the advertising and communications giant fell 5% in the three months to March end, to £3.24bn, or by 0.7% on a like-for-like basis.

Revenues less pass-through costs were down 2.7% on an underlying basis, at £2.48bn. Within that, all regions saw declines, including a 4.5% slide in western continental Europe and a 5.5% fall in the UK.

However, in North America - WPP's biggest market - revenues eased just 0.1%, at £992m.

Mark Read, chief executive, said: "Our financial performance in the first quarter was in line with our expectations, reflecting macroeconomic challenges and the timing of a new business. We expect these factors to continue in the second quarter, with performance anticipated to improve in the second half."

WPP expects full-year like-for-like revenues less pass-through costs to come in between -2% and 0.0%.

However, Read acknowledged that the Donald Trump's swingeing tariff regime - which came into effect after the period end - could impact client spending going forward.

He said: "While WPP is not itself directly affected by tariffs, they will impact a number of our clients as well as the broader economy.

"At this point we have not seen any significant change in client spending, and we reiterate our full-year guidance, which already reflected a challenging environment."

Aarin Chiekrie, equity analyst at Hargreaves Lansdown, said: "In a fiercely competitive advertising area, WPP is struggling to spark fresh ideas that could kickstart its return to growth.

"With this weakness set to continue into the second quarter, WPP's leaving itself a lot of work to do late in the year, and there could be room for disappointment as the year progresses."

As at 0845 BST, shares in the blue chip were up 2% at 570.23p. The stock has lost 31% in 2025 to date.

Share this article

Related Sharecast Articles

RBC Capital ups price target on Hikma
(Sharecast News) - RBC Capital Markets has upped both forecasts and its price target for blue chip generics specialist Hikma Pharmaceuticals.
Home Depot won't hike prices in response to tariffs, Q1 sales fall
(Sharecast News) - US do-it-yourself chain Home Depot on Tuesday held full-year sales forecasts and said it did not expect to raise prices in response to President Donald trump's tariffs.
Poolbeg raises nearly £5m to progress clinical trials
(Sharecast News) - Shares in biopharmaceutical group Poolbeg Pharma sank on Tuesday after the company revealed wider losses for the 2024 financial year as it raised nearly £5m in an oversubscribed placing as it progresses two key clinical trials.
Berenberg starts coverage of Accesso Technology at 'buy'
(Sharecast News) - Berenberg initiated coverage of Accesso Technology on Tuesday with a 'buy' rating and 775p price target.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.